))
56. How many paragraphs in Introduction?
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on October 30, 2025 15:07 (
What now? This series will be checked again in the next hour. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 491578272 series 3493940
内容由Dr. Synaptologica提供。所有播客内容（包括剧集、图形和播客描述）均由 Dr. Synaptologica 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
In combination with the last episode, we will talk about an introduction to how to read the Introduction section. With these two episodes, we will be ready to analyze the content details, from the next episode.
We are reading the paper written by Dr. Katalin Karikó & Dr. Drew Weissman, that led to the Nobel Prize in Physiology or Medicine 2023. We call it the Milestone Article 1. Here are two sets of links related to the paper.
Milestone Article 1:
- “Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA” by Karikó, Buckstein, Ni & Weissman. Immunity, 23(2): 165-75, 2005.
- HTML: https://doi.org/10.1016/j.immuni.2005.06.008
- PDF: https://www.cell.com/immunity/pdf/S1074-7613(05)00211-6.pdf
- PubMed: https://pubmed.ncbi.nlm.nih.gov/16111635/
Copyright of the paper (as of March, 2025):
- See the pull-down menu “Article Info” near the top of the article webpage (Use the DOI above to reach it).
- Check the “User License” section which lists the “Elsevier user license”:
--- http://www.elsevier.com/open-access/userlicense/1.0/
--- https://www.elsevier.com/about/policies-and-standards/open-access-licenses/elsevier-user
This episode = mini-series: reading-36.
(My email is active. But my website is under construction. Please wait for a while. Thank you for the patience!)
61集单集
分享
